Mepitel Film Breast
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21-100
SponsorNational University Hospital, Singapore
About this trial
Primary Objective To examine the tolerability of Mepitel Film in the prevention of RD patients undergoing whole breast or chest wall RT in the hot and humid weather in Singapore
Secondary Objectives To evaluate the incidence of acute radiation dermatitis, quality of life, satisfaction, and cost analysis of Mepitel Film use.
Eligibility criteria
Qualifiers
Age ≥ 21 years old (legal age of maturity in Singapore)
Male or female
Informed consent
Patients have undergone a mastectomy with or without reconstruction or breast-conserving surgery.
Disqualifiers
Prior RT to any portion of the planned treatment site.
Patients will receive partial breast external beam RT, proton beam therapy, or brachytherapy.
Patients with active rash, pre-existing dermatitis, or other conditions within the treatment area may make skin assessment for the study difficult per treating physician discretion.
Known history of adhesive, tape or silicon allergy or sensitivity.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
60 Participants
are grouped into 2 trial groupsSponsors and collaborators
National University Hospital, Singapore
Lead sponsor
Molnlycke Health Care AB
Collaborator
Source ClinicalTrials.gov